Cyklokapron (Tranexamic acid)

Brand Options

arrow pointer

Brand Name : Cyklokapron

Marketing Authorization Holder : Pfizer

Prescription Required

 
 

Generic Option

arrow pointer2

Generic Name : Tranexamic acid

Manufactured By : Authorized UK Generic

Prescription Required

 
 

Product Details

Cyklokapron

Information about Cyklokapron (Tranexamic Acid)

Cyklokapron is a brand name for tranexamic acid, a synthetic derivative of the amino acid lysine. It is an antifibrinolytic agent that helps prevent excessive bleeding by inhibiting the breakdown of fibrin, a protein crucial for blood clot formation.

Product Highlights

  • To reduce menstrual blood loss.
  • Used to minimize bleeding in surgical procedures, including dental and orthopedic surgeries.
  • Helps control bleeding in trauma patients.
  • Can be used topically or orally to manage persistent nosebleeds.
  • Assists in the management of bleeding disorders like hemophilia and von Willebrand disease.

Key Ingredient

  • Tranexamic Acid

Key Benefits

  • Effective in controlling and reducing excessive bleeding in various medical conditions.
  • Available in various forms, such as tablets, injectable solutions, and topical treatments.
  • Can minimize the requirement for blood products in surgical or trauma situations.
  • Useful in a range of conditions from gynecological issues to trauma management.

Direction of Use

  • Oral Tablets: Typically taken 1-3 times daily, depending on the condition and severity. Dosage may vary based on the specific indication and patient needs.
  • Injectable Form: Administered intravenously, often in a hospital or clinical setting, with dosage and frequency determined by the treating physician.
  • Topical Application: Applied directly to the affected area for conditions like nosebleeds or localized bleeding.

Safety Concerns

  • May include nausea, vomiting, diarrhea, headache, and dizziness.
  • Rare but can include thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism) due to increased clotting tendency.
  • Regular monitoring of kidney function and blood clotting parameters may be required during long-term use or in patients with pre-existing conditions.

Avoid Cyklokapron (Tranexamic Acid) If

  • History of hypersensitivity or allergic reactions to tranexamic acid or any other ingredients in the formulation.
  • Conditions such as deep vein thrombosis, pulmonary embolism, or other blood clotting disorders.
  • Because of the potential for accumulation and heightened risk of side effects.
  • Caution is advised, and use should be carefully considered and monitored by a healthcare provider.


Image Image Image Image